Phosphothreonine as a Catalytic Residue in Peptide-Mediated Asymmetric Transfer Hydrogenations of 8-Aminoquinolines

Angewandte Chemie - International Edition

Volumn 54, Issue 38, 2015, Pages 11173-11176

  Shugrue, Christopher R ^a   Miller, Scott J ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

asymmetric catalysis; peptides; phosphothreonine; quinoline; transfer hydrogenation

Indexed keywords

CATALYSIS; CATALYSTS; ENANTIOSELECTIVITY; HYDROGEN BONDS; HYDROGENATION; SUBSTRATES;

AMINO FUNCTIONALITY; ASYMMETRIC CATALYSIS; ASYMMETRIC CATALYSTS; ASYMMETRIC TRANSFER HYDROGENATION; HYDROGEN BONDING INTERACTIONS; PHOSPHOTHREONINE; QUINOLINE; TRANSFER HYDROGENATIONS;

PEPTIDES;

8-AMINOQUINOLINE; AMINOQUINOLINE DERIVATIVE; HYDROGEN; PEPTIDE; PHOSPHOTHREONINE;

CHEMISTRY; ENZYME ACTIVE SITE;

AMINOQUINOLINES; CATALYTIC DOMAIN; HYDROGEN; PEPTIDES; PHOSPHOTHREONINE;

EID: 84938632894     PISSN: 14337851     EISSN: 15213773     Source Type: Journal    
DOI: 10.1002/anie.201505898     Document Type: Article

References (53)

1. Selected reviews:
2. M. Terada, Synthesis 2010, 1929–1982;
3. A. Zamfir, S. Schenker, M. Freund, B. S. Tsogoeva, Org. Biomol. Chem. 2010, 8, 5262–5276;
4. M. Rueping, A. Kuenkel, I. Atodiresei, Chem. Soc. Rev. 2011, 40, 4539–4549;
5. D. Parmar, E. Sugiono, S. Raja, M. Rueping, Chem. Rev. 2014, 114, 9047–9153.
6. For selected examples, see:
7. T. Pawson, D. J. Scott, Science 1997, 278, 2075–2080;
8. P. J. Lu, X. Z. Zhou, M. H. Shen, K. P. Lu, Science 1999, 283, 1325–1328.
9. Selected reviews:
10. T. Hunter, Cell 2000, 100, 113–127;
11. M. B. Yaffe, A. E. H. Elia, Curr. Opin. Cell Biol. 2001, 13, 131–138.
12. Selected examples:
13. A. Dermenci, P. S. Selig, R. A. Domaoal, K. A. Spasov, K. S. Anderson, S. J. Miller, Chem. Sci. 2011, 2, 1568–1572;
14. P. A. Lichtor, S. J. Miller, Nat. Chem. 2012, 4, 990–995.
15. Selected reports:
16. M. Rueping, A. P. Antonchick, T. Theissmann, Angew. Chem. Int. Ed. 2006, 45, 3683–3686;
17. Angew. Chem. 2006, 118, 3765–3768;
18. Q. S. Guo, D. M. Du, J. T. Xu, Angew. Chem. Int. Ed. 2008, 47, 759–762;
19. Angew. Chem. 2008, 120, 771–774;
20. M. Rueping, M. Stoechel, E. Sugiono, T. Theissmann, Tetrahedron 2010, 66, 6565–6568;
21. M. Rueping, T. Theissmann, M. Stoeckel, A. P. Antonchick, Org. Biomol. Chem. 2011, 9, 6844–6850;
22. X. F. Cai, M. W. Chen, Z. S. Ye, R. N. Guo, L. Shi, Y. Q. Li, Y. G. Zhou, Chem. Asian J. 2013, 8, 1381–1385;
23. J. Stemper, K. Isaac, J. Pastor, G. Frison, P. Retailleau, A. Voituriez, J. F. Betzer, A. Marinetti, Adv. Synth. Catal. 2013, 355, 3613–3624;
24. A. Aillerie, V. Lemau de Talancé, A. Moncomble, T. Bousquet, L. Pélinski, Org. Lett. 2014, 16, 2982–2985;
25. X. F. Cai, R. N. Guo, G. S. Feng, B. Wu, Y. G. Zhou, Org. Lett. 2014, 16, 2680–2683.
26. Selected reports of asymmetric reductions of 1,10-disubstituted phenanthrolines:
27. K. Skupinska, E. J. McEachern, R. T. Skerlj, G. J. Bridgr, J. Org. Chem. 2002, 67, 7890–7893;
28. C. Metallinos, F. B. Barrett, S. Xu, Synlett 2008, 720–724;
29. T. Wang, F. Chen, J. Qin, Y.-M. He, Q.-H. Fan, Angew. Chem. Int. Ed. 2013, 52, 7172–7176;
30. Angew. Chem. 2013, 125, 7313–7317.
31. Seminal reports:
32. D. Uraguchi, M. Terada, J. Am. Chem. Soc. 2004, 126, 5356–5357;
33. T. Akiyama, J. Itoh, K. Yokota, K. Fuchibe, Angew. Chem. Int. Ed. 2004, 43, 1566–1568;
34. Angew. Chem. 2004, 116, 1592–1594.
35. F. Xu, D. Huang, C. Han, W. Shen, X. Lin, Y. Wang, J. Org. Chem. 2010, 75, 8677–8680;
36. G. B. Rowland, H. Zhang, E. B. Rowland, S. Chennamadhavuni, Y. Wang, J. C. Antilla, J. Am. Chem. Soc. 2005, 127, 15696–15697.
37. J. Clardy, C. Walsh, Nature 2004, 432, 829–837;
38. S. Han, S. J. Miller, J. Am. Chem. Soc. 2013, 135, 12414–12421;
39. S. Yoganathan, S. J. Miller, J. Med. Chem. 2015, 58, 2367–2377.
40. A. G. Doyle, E. N. Jacobsen, Chem. Rev. 2007, 107, 5713–5743.
41. N. Vale, R. Moreira, P. Gomes, Eur. J. Med. Chem. 2009, 44, 937–953;
42. K. Kaur, M. Jain, R. P. Reddy, R. Jain, Eur. J. Med. Chem. 2010, 45, 3245–3264;
43. M. Delves, D. Plouffe, C. Scheurer, S. Meister, S. Wittlin, E. A. Winzeler, R. E. Sinden, D. Lerory, PLOS Med. 2012, 9, e1001169.
44. M. M. Vasbinder, E. R. Jarvo, S. J. Miller, Angew. Chem. Int. Ed. 2001, 40, 2824–2827;
45. Angew. Chem. 2001, 113, 2906–2909;
46. D. K. Romney, S. M. Colvin, S. J. Miller, J. Am. Chem. Soc. 2014, 136, 14019–14022.
47. 31P as particularly diagnostic. The identity of the optimized catalyst (5 e) for this work was determined by additional characterization and also confirmed as the monobasic phosphoric acid by combustion analysis. See the Supporting Information for details.
48. E. A. Colby Davie, S. M. Mennen, Y. Xu, S. J. Miller, Chem. Rev. 2007, 107, 5759–5812.
49. G. T. Copeland, E. R. Jarvo, S. J. Miller, J. Org. Chem. 1998, 63, 6784–6785.
50. A. J. Metrano, S. J. Miller, J. Org. Chem. 2014, 79, 1542–1554.
51. See the Supporting Information for structure and details. CCDC 1412999 (7 f) contains the supplementary crystallographic data for this paper. These data can be obtained free of charge from The Cambridge Crystallographic Data Centre.
52. The singlet at 8.7 ppm corresponds to the aromatic CH of HEox, thus showing that 5 e converts HEH to HEox.
53. G. Barbieri, R. Benassi, P. Lazzeretti, L. Schenetti, F. Taddei, Org. Magn. Resonance 1975, 7, 451–454.